Drug shortages homepage

Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
HUMULIN R ELI LILLY CANADA INC Anticipated shortage 100UNIT Updated Report 2024-04-15 225163
DIPRIVAN 1% ASPEN PHARMACARE CANADA INC. Anticipated shortage 10MG Updated Report 2024-04-15 222698
DIPRIVAN 1% ASPEN PHARMACARE CANADA INC. Anticipated shortage 10MG Updated Report 2024-04-15 222695
ARTHROTEC 50 PFIZER CANADA ULC Actual shortage 200MCG 50MG Updated Report 2024-04-15 224337
XYLOCAINE 1% W EPINEPHRINE 1:100000 ASPEN PHARMACARE CANADA INC. Anticipated shortage 0.01MG 10MG Updated Report 2024-04-15 220858
DIPRIVAN 1% ASPEN PHARMACARE CANADA INC. Anticipated shortage 10MG New Report 2024-04-15 225152
SENSORCAINE ASPEN PHARMACARE CANADA INC. Actual shortage 2.5MG Updated Report 2024-04-15 203911
XYLOCAINE 1% W EPINEPHRINE 1:200000 ASPEN PHARMACARE CANADA INC. Anticipated shortage 5MCG 10MG Updated Report 2024-04-15 222673
XYLOCAINE 2% W EPINEPHRINE 1:200000 ASPEN PHARMACARE CANADA INC. Anticipated shortage 5MCG 20MG Updated Report 2024-04-15 222670
TELMISARTAN SANIS HEALTH INC Actual shortage 40MG Updated Report 2024-04-15 223276

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
MYLAN-VERAPAMIL MYLAN PHARMACEUTICALS ULC Discontinued 80MG Updated Report 2024-04-12 224846
TD ADSORBED SANOFI PASTEUR LIMITED To be discontinued 5LF 2LF Updated Report 2024-04-10 206909
PEDIACEL SANOFI PASTEUR LIMITED To be discontinued 5MCG 20MCG 30MCG 10MCG 32UNIT 8UNIT 40UNIT 5LF 15LF 20MCG 3MCG Updated Report 2024-04-10 206912
DENTICARE CHLORHEXIDINE GLUCONATE ORAL RINSE 0.12% AMD MEDICOM INC Discontinued 0.12% New Report 2024-04-09 224698
DENTICARE CHLORHEXIDINE GLUCONATE ORAL RINSE 0.12% AMD MEDICOM INC Discontinued 0.12% Updated Report 2024-04-09 224713